Literature DB >> 25515529

Psoriasis-associated IgA nephropathy under infliximab therapy.

Nicolas Kluger1, Aurélie Du-Thanh, Didier Bessis, Marie-Françoise Servel, Georges Mourad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25515529     DOI： 10.1111/ijd.12622

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

1.  Adalimumab-induced IgA nephropathy.

Authors:  Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

Review 3.  Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Sukit Raksasuk
Journal:  Int Urol Nephrol       Date:  2018-04-11       Impact factor: 2.370

4.  IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.

Authors:  Yuka Segawa; Ryo Ishida; Fuminao Kanehisa; Kunihiro Nakai; Mari Morimoto; Masafumi Seno; Mayuka Nakayama; Tetsuro Kusaba; Norito Katoh; Keiichi Tamagaki
Journal:  BMC Nephrol       Date:  2020-08-26       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.